Corresponding Authors: Qingwu Yang, MD, PhD, Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main St, Shapingba District, Chongqing 400037, China (yangqwmlys@163.com); Raul G. Nogueira, MD, Department of Neurology, Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine, 80 Jesse Hill Jr Dr SE, Room 8D108A, Atlanta, GA 30303 (raul.g.nogueira@emory.edu).
Accepted for Publication: December 3, 2020.
Author Contributions: Drs Q. Yang and Nogueira had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Zi and Z. Qiu are co–first authors. Drs Q. Yang and Nogueira are co–corresponding authors.
Concept and design: Zi, Z. Qiu, F. Li, Sang, D. Wu, W. Liu, Shuai, Nogueira, Q. Yang.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: Zi, Z. Qiu, F. Li, Sang, D. Wu, W. Luo, W. Liu, Z. Zhou, Bai, Q. Yang.
Statistical analysis: W. Luo, Shuai Liu, X. Huang.
Obtained funding: Zi, Z. Qiu, F. Li, Sang, Q. Yang.
Administrative, technical, or material support: Zi, Z. Qiu, F. Li, Sang, D. Wu, W. Luo, Shuai Liu, Yuan, Song, Z. Shi, W. Huang, Min Zhang, W. Liu, Z. Guo, T. Qiu, Q. Shi, P. Zhou, L. Wang, Fu, Shudong Liu, S. Yang, S. Zhang, Z. Zhou, X. Huang, Y. Wang, J. Luo, Bai, Min Zhang, Y. Wu, Zeng, Wan, C. Wen, H. Wen, Ling, Z. Chen, Peng, Ai, F. Guo, H. Li, J. Guo, Guan, Zhiyi Wang, Y. Liu, Pu, Zhen Wang, H. Liu, L. Chen, J. Huang, G. Yang, Gong, Shuai, Q. Yang.
Supervision: Zi, Z. Qiu, F. Li, Sang, D. Wu, Shuai, Nogueira, Q. Yang.
Conflict of Interest Disclosures: Dr Nogueira reported receiving consulting fees for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Imperative Care, Medtronic, Phenox, Prolong Pharmaceuticals, and Stryker Neurovascular and having stock options for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, and Perfuze. No other disclosures were reported.
Funding/Support: The study was supported by grants 81525008, 81901236, 81801157 from the National Natural Science Foundation of China, 2019ZX001 from the Chongqing Major Disease Prevention and Control Technology Research Project, 2019XLC2008 2019XLC3016 from the Clinical Medical Research Talent Training Program of Army Medical University, and 2018JSLC0017 from the Major Clinical Innovation Technology Project of the Second Affiliated Hospital of Army Medical University.
Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The DEVT Trial members are listed in Supplement 1.
Data Sharing Statement: See Supplement 5.
1.Bracard
S , Ducrocq
X , Mas
JL ,
et al; THRACE investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
Lancet Neurol. 2016;15(11):1138-1147. doi:
10.1016/S1474-4422(16)30177-6
PubMedGoogle ScholarCrossref 11.Yaghi
S , Eisenberger
A , Willey
JZ . Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment.
JAMA Neurol. 2014;71(9):1181-1185. doi:
10.1001/jamaneurol.2014.1210PubMedGoogle ScholarCrossref 15.Qiu
Z , Liu
H , Li
F ,
et al; DEVT study investigators. DEVT: A randomized, controlled, multicenter trial of direct endovascular treatment versus standard bridging therapy for acute stroke patients with large vessel occlusion in the anterior circulation—protocol.
Int J Stroke. 2020;1747493020925349. doi:
10.1177/1747493020925349
PubMedGoogle Scholar 16.Zaidat
OO , Yoo
AJ , Khatri
P ,
et al; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization working group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.
Stroke. 2013;44(9):2650-2663. doi:
10.1161/STROKEAHA.113.001972
PubMedGoogle ScholarCrossref 18.Wang
H , Zi
W , Hao
Y ,
et al; ACTUAL Investigators. Direct endovascular treatment: an alternative for bridging therapy in anterior circulation large-vessel occlusion stroke.
Eur J Neurol. 2017;24(7):935-943. doi:
10.1111/ene.13311
PubMedGoogle ScholarCrossref 19.Broeg-Morvay
A , Mordasini
P , Bernasconi
C ,
et al. Direct mechanical intervention versus combined intravenous and mechanical intervention in large artery anterior circulation stroke: a matched-pairs analysis.
Stroke. 2016;47(4):1037-1044. doi:
10.1161/STROKEAHA.115.011134
PubMedGoogle ScholarCrossref 23.Goyal
M , Menon
BK , van Zwam
WH ,
et al; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
Lancet. 2016;387(10029):1723-1731. doi:
10.1016/S0140-6736(16)00163-X
PubMedGoogle ScholarCrossref 27.Constant Dit Beaufils
P , Preterre
C , De Gaalon
S ,
et al; Endovascular Treatment in Ischemic Stroke (ETIS) Research Investigators. Prognosis and risk factors associated with asymptomatic intracranial hemorrhage after endovascular treatment of large vessel occlusion stroke: a prospective multicenter cohort study.
Eur J Neurol. 2020;0(0):1-9. doi:
10.1111/ene.14539
PubMedGoogle Scholar 28.Hill
MD , Goyal
M , Menon
BK ,
et al; ESCAPE-NA1 Investigators. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
Lancet. 2020;395(10227):878-887. doi:
10.1016/S0140-6736(20)30258-0
PubMedGoogle ScholarCrossref